AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishino, M.
Right arrow Articles by Mukaihara, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishino, M.
Right arrow Articles by Mukaihara, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?

Effects of Tamoxifen on Hepatic Fat Content and the Development of Hepatic Steatosis in Patients with Breast Cancer: High Frequency of Involvement and Rapid Reversal After Completion of Tamoxifen Therapy

Mizuki Nishino1, Katsumi Hayakawa1, Yoshiaki Nakamura2, Taisuke Morimoto2 and Sumio Mukaihara2

1 Department of Radiology, Kyoto City Hospital, 1-2 Higashi-takada-cho, Mibu, Nakagyo-ku, Kyoto 604-8845, Japan.
2 Department of Surgery, Kyoto City Hospital, Kyoto 604-8845, Japan.



View larger version (38K):

[in a new window]
  		Fig. 1. —Chart shows mean hepatic CT attenuation values of all patients throughout study. Among mean CT attenuation values of liver obtained each year while patients were undergoing tamoxifen therapy, lowest value was used as "During" (p < 0.0001, paired t test). Each color represents a different patient.

 


View larger version (95K):

[in a new window]
  		Fig. 2A. —55-year-old woman with representative CT findings of transient hepatic steatosis. Unenhanced abdominal CT image obtained before tamoxifen therapy shows normal homogeneous CT attenuation of liver, which is slightly higher than that of spleen. Liver—spleen ratio was 1.3.

 


View larger version (98K):

[in a new window]
  		Fig. 2B. —55-year-old woman with representative CT findings of transient hepatic steatosis. Unenhanced abdominal CT image obtained after 1 year of tamoxifen therapy shows decrease in CT attenuation of liver predominantly in right lobe, with liver—spleen ratio of 0.3. Note development of moderate hepatic steatosis.

 


View larger version (102K):

[in a new window]
  		Fig. 2C. —55-year-old woman with representative CT findings of transient hepatic steatosis. Unenhanced abdominal CT image obtained after 2 years of tamoxifen therapy shows further decrease in CT attenuation of liver in right lobe, with liver—spleen ratio of 0.1. Degree of steatosis is still moderate.

 


View larger version (102K):

[in a new window]
  		Fig. 2D. —55-year-old woman with representative CT findings of transient hepatic steatosis. Unenhanced abdominal CT image obtained 1 year after completion of tamoxifen therapy shows that CT attenuation of liver has returned to normal, with liver—spleen ratio of 1.1. Steatosis is not present.

 


View larger version (26K):

[in a new window]
  		Fig. 3. —Chart shows liver—spleen ratio in 29 patients with hepatic steatosis before, during, and after tamoxifen therapy. Liver—spleen ratio was calculated using lowest CT attenuation value of liver among values in the eight Couinaud segments. Each color represents a different patient.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.